Your browser doesn't support javascript.
loading
Cross-Linked Reverse Vesicle as a General and Effective Vehicle for Hydrophobic Drugs.
Zhang, Jing; Li, Chuanqi; Liao, Chunyan; Zhao, Puchen; Yu, Yunlong; Zhang, Shiyong.
Afiliação
  • Zhang J; National Engineering Research Center for Biomaterials , Sichuan University , 29 Wangjiang Road , Chengdu 610064 , China.
  • Li C; National Engineering Research Center for Biomaterials , Sichuan University , 29 Wangjiang Road , Chengdu 610064 , China.
  • Liao C; National Engineering Research Center for Biomaterials , Sichuan University , 29 Wangjiang Road , Chengdu 610064 , China.
  • Zhao P; National Engineering Research Center for Biomaterials , Sichuan University , 29 Wangjiang Road , Chengdu 610064 , China.
  • Yu Y; National Engineering Research Center for Biomaterials , Sichuan University , 29 Wangjiang Road , Chengdu 610064 , China.
  • Zhang S; National Engineering Research Center for Biomaterials , Sichuan University , 29 Wangjiang Road , Chengdu 610064 , China.
Langmuir ; 35(20): 6676-6682, 2019 05 21.
Article em En | MEDLINE | ID: mdl-31039611
ABSTRACT
It is well-known that vesicles serve as an excellent delivery platform for hydrophilic drugs. However, there is still a lack of a general and effective platform for hydrophobic drug loading. We herein disclose that water-soluble cross-linked reverse vesicles (cRVs) constructed from anionic surfactant 1, a counterpart of normal vesicles, would be excellent vehicles for hydrophobic drugs, the drug loading content (DLC) for which arrived up to 21.1%, 19.8%, and 25.8%, respectively, for three anticancer drugs, paclitaxel, camptothecin, and carmofur. This represents a general drug carrier with high drug loading content for various hydrophobic drugs without the assistance of other external forces. In addition to drug loading superiority, the cRVs were also characterized by robust stability, specific stimulus response, easy postfunctionalization, and good biocompatibility and thus are promising candidates for drug delivery systems.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tensoativos / Portadores de Fármacos / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tensoativos / Portadores de Fármacos / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article